Funnelfeedr Logo

Disruptive Pharma AB (publ)

Sverige556755-3226Active

Swedish biotech developing novel kidney disease therapies based on proprietary peptides.

Biotechnology Companyguardtherapeutics.com

Oversikt

5–9
Ansatte
≤1t SEK
Omsetning
2008
Grunnlagt

Nøkkelbeslutningstakere

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

+9 flere kontakter i Funnelfeedr

Beskrivelse

Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...

Tagger

B2BHealthcarePharmaceuticalsProfessional ServicesPublicly ListedTechnologyWhite Collar

Nøkkelord

BiotechnologyClinical StageDrug DevelopmentKidney DiseasePharmaRMC-035

Teknologier i bruk

YiijQueryVimeoBootstrapCraft CMSFont AwesomeModernizrPHP

Bedriftsinformasjon

Bransje
Annan naturvetenskaplig och teknisk forskning och utveckling
Juridisk form
Aktiebolag
MVA-nummer
SE556755322601

Beslutningstakere

13 kontakter i Funnelfeedr

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

Sara Thuresson

Head of Clinical Operations

Fredrik Lehmann

Board Member

Göran Forsberg

Board Member

Johannes Hulthe

Board Member

Michael Reusch

CMO

Johan Bygge

Chairman of the Board

Hege Hellström

Board Member

Peter Gilmour

Head of Preclinical Science

Andre kontakter

Mikael Widell

IR Contact

@guardtherapeutics.com

Lignende bedrifter

20 lignende bedrifter i Funnelfeedr

Utforsk mer

Spørsmål om Disruptive Pharma AB (publ)

Vil du se Funnelfeedr i aksjon?

Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.

Book en demo